These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16223773)

  • 21. The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.
    Murphy CT; Hall LJ; Hurley G; Quinlan A; MacSharry J; Shanahan F; Nally K; Melgar S
    Infect Immun; 2012 Aug; 80(8):2712-23. PubMed ID: 22615252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting sphingosine-1-phosphate in hematologic malignancies.
    Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S
    Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
    Spijkers LJ; Alewijnse AE; Peters SL
    Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
    Högenauer K; Billich A; Pally C; Streiff M; Wagner T; Welzenbach K; Nussbaumer P
    ChemMedChem; 2008 Jul; 3(7):1027-9. PubMed ID: 18383466
    [No Abstract]   [Full Text] [Related]  

  • 27. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
    Xu M; Liu D; Ding LH; Ma KL; Wu M; Lv LL; Wen Y; Liu H; Tang RN; Liu BC
    Acta Pharmacol Sin; 2014 Dec; 35(12):1537-45. PubMed ID: 25399649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rate.
    Jary E; Bee T; Walker SR; Chung SK; Seo KC; Morris JC; Don AS
    Mol Pharmacol; 2010 Oct; 78(4):685-92. PubMed ID: 20610734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
    Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
    J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin.
    Pabst O; Herbrand H; Willenzon S; Worbs T; Schippers A; Müller W; Bernhardt G; Förster R
    J Immunol; 2006 Feb; 176(3):1474-80. PubMed ID: 16424175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.
    Kaneider NC; Lindner J; Feistritzer C; Sturn DH; Mosheimer BA; Djanani AM; Wiedermann CJ
    FASEB J; 2004 Aug; 18(11):1309-11. PubMed ID: 15208267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.
    Payne SG; Oskeritzian CA; Griffiths R; Subramanian P; Barbour SE; Chalfant CE; Milstien S; Spiegel S
    Blood; 2007 Feb; 109(3):1077-85. PubMed ID: 17008548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine.
    Mansoor M; Melendez AJ
    Rev Recent Clin Trials; 2008 Jan; 3(1):62-9. PubMed ID: 18474015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration.
    Hwang SJ; Kim JH; Kim HY; Kim S; Chung DH
    Lab Invest; 2010 Jan; 90(1):9-19. PubMed ID: 19823172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
    Jo SK; Bajwa A; Ye H; Vergis AL; Awad AS; Kharel Y; Lynch KR; Okusa MD
    Kidney Int; 2009 Jan; 75(2):167-75. PubMed ID: 18971925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus.
    Zhi L; Kim P; Thompson BD; Pitsillides C; Bankovich AJ; Yun SH; Lin CP; Cyster JG; Wu MX
    J Immunol; 2011 Sep; 187(5):2244-51. PubMed ID: 21788441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.